BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 26785814)

  • 1. Distinct mutation accumulation rates among tissues determine the variation in cancer risk.
    Hao D; Wang L; Di LJ
    Sci Rep; 2016 Jan; 6():19458. PubMed ID: 26785814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploring the implications of distinct mutational signatures and mutation rates in aging and cancer.
    Fox EJ; Salk JJ; Loeb LA
    Genome Med; 2016 Mar; 8(1):30. PubMed ID: 26987311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accumulation of somatic mutations in TP53 in gastric epithelium with Helicobacter pylori infection.
    Shimizu T; Marusawa H; Matsumoto Y; Inuzuka T; Ikeda A; Fujii Y; Minamiguchi S; Miyamoto S; Kou T; Sakai Y; Crabtree JE; Chiba T
    Gastroenterology; 2014 Aug; 147(2):407-17.e3. PubMed ID: 24786892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Random mutations' role in cancer.
    Cancer Discov; 2015 Apr; 5(4):OF3. PubMed ID: 25665809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer etiology: Variation in cancer risk among tissues is poorly explained by the number of gene mutations.
    López-Lázaro M
    Genes Chromosomes Cancer; 2018 Jun; 57(6):281-293. PubMed ID: 29377495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tissue-specific mutation accumulation in human adult stem cells during life.
    Blokzijl F; de Ligt J; Jager M; Sasselli V; Roerink S; Sasaki N; Huch M; Boymans S; Kuijk E; Prins P; Nijman IJ; Martincorena I; Mokry M; Wiegerinck CL; Middendorp S; Sato T; Schwank G; Nieuwenhuis EE; Verstegen MM; van der Laan LJ; de Jonge J; IJzermans JN; Vries RG; van de Wetering M; Stratton MR; Clevers H; Cuppen E; van Boxtel R
    Nature; 2016 Oct; 538(7624):260-264. PubMed ID: 27698416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clock-like mutational processes in human somatic cells.
    Alexandrov LB; Jones PH; Wedge DC; Sale JE; Campbell PJ; Nik-Zainal S; Stratton MR
    Nat Genet; 2015 Dec; 47(12):1402-7. PubMed ID: 26551669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Substantial contribution of extrinsic risk factors to cancer development.
    Wu S; Powers S; Zhu W; Hannun YA
    Nature; 2016 Jan; 529(7584):43-7. PubMed ID: 26675728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Challenging the axiom: does the occurrence of oncogenic mutations truly limit cancer development with age?
    DeGregori J
    Oncogene; 2013 Apr; 32(15):1869-75. PubMed ID: 22751134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Mutational tumor profiles beyond organ and tissue specificity: implications for diagnostics and clinical study design].
    Klauschen F
    Pathologe; 2014 Nov; 35 Suppl 2():277-80. PubMed ID: 25394977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Half or more of the somatic mutations in cancers of self-renewing tissues originate prior to tumor initiation.
    Tomasetti C; Vogelstein B; Parmigiani G
    Proc Natl Acad Sci U S A; 2013 Feb; 110(6):1999-2004. PubMed ID: 23345422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Problems of somatic mutation and cancer.
    Frank SA; Nowak MA
    Bioessays; 2004 Mar; 26(3):291-9. PubMed ID: 14988930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The population dynamics of cancer: a Darwinian perspective.
    Vineis P; Berwick M
    Int J Epidemiol; 2006 Oct; 35(5):1151-9. PubMed ID: 16987840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular epidemiology and the genetics of environmental cancer.
    Shields PG; Harris CC
    JAMA; 1991 Aug; 266(5):681-7. PubMed ID: 2072479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrating epithelial cancer, aging stroma and cellular senescence.
    Krtolica A; Campisi J
    Adv Gerontol; 2003; 11():109-16. PubMed ID: 12820530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficiency of carcinogenesis: is the mutator phenotype inevitable?
    Beckman RA
    Semin Cancer Biol; 2010 Oct; 20(5):340-52. PubMed ID: 20934514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Mouse Model That Reproduces the Developmental Pathways and Site Specificity of the Cancers Associated With the Human BRCA1 Mutation Carrier State.
    Liu Y; Yen HY; Austria T; Pettersson J; Peti-Peterdi J; Maxson R; Widschwendter M; Dubeau L
    EBioMedicine; 2015 Oct; 2(10):1318-30. PubMed ID: 26629527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutations and epimutations in the origin of cancer.
    Peltomäki P
    Exp Cell Res; 2012 Feb; 318(4):299-310. PubMed ID: 22182599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A simple algebraic cancer equation: calculating how cancers may arise with normal mutation rates.
    Calabrese P; Shibata D
    BMC Cancer; 2010 Jan; 10():3. PubMed ID: 20051132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Commonalities and differences in the mutational signature and somatic driver mutation landscape across solid and hollow viscus organs.
    Ng AS; Chan DKH
    Oncogene; 2023 Sep; 42(37):2713-2724. PubMed ID: 37573406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.